Biocryst Pharmaceuticals (BCRX) Current Deferred Revenue (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Current Deferred Revenue came in at $5.4 million in Q1 2026, up 936.21% on a QoQ basis from $522000.0 in Q3 2023.
Biocryst Pharmaceuticals (BCRX) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 15 years of Current Deferred Revenue data on file, last reported at $5.4 million in Q1 2026.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (changed N/A YoY) and the FY2022 annual result came in at $1.2 million, down 13.86% from the prior year.
- Current Deferred Revenue advanced to $5.4 million in Q1 2026, from $522000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $5.4 million in Q1 2026 to a low of $522000.0 in Q3 2023.
- A 3-year average of $1.8 million and a median of $1.5 million in 2022 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2022 — Current Deferred Revenue soared 263.21% — and 2023, when it plunged 66.41%.
- Tracing BCRX's Current Deferred Revenue over 3 years: stood at $1.2 million in 2022, then slumped by 57.35% to $522000.0 in 2023, then soared by 936.21% to $5.4 million in 2026.
- The last three Current Deferred Revenue figures came in at $5.4 million (Q1 2026), $522000.0 (Q3 2023), and $1.8 million (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.32 Mn |
| Mar 31, 2026 | 5.41 Mn |
| Sep 30, 2023 | 522,000.00 |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 602,000.00 |
| Jun 30, 2021 | 551,000.00 |
| Mar 31, 2021 | 405,000.00 |
| Dec 31, 2020 | 150,000.00 |
| Sep 30, 2020 | 432,000.00 |
| Mar 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 2.12 Mn |
| Sep 30, 2019 | 221,000.00 |
| Jun 30, 2019 | 221,000.00 |
| Mar 31, 2019 | 221,000.00 |